A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis (NCT06807424)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy of icotrokinra (JNJ-77242113) compared to placebo in biologic-experienced and biologic-naive participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
Who can join: Review the eligibility criteria below.
Location: AARA Clinical Research — Glendale, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (236 Sites)
Showing the first 25 of 236 sites.
- AARA Clinical Research — Glendale, Arizona
- AARA Clinical Research 1 — Mesa, Arizona
- Arthritis and Rheumatism Associates ARA Jonesboro — Jonesboro, Arkansas
- Clinical Research of West Florida — Clearwater, Florida
- Omega Research Consultants — DeBary, Florida
- Suncoast Clinical Research — New Port Richey, Florida
- Integral Rheumatology And Immunology Specialists — Plantation, Florida
- Clinical Research of West Florida 1 — Tampa, Florida
- Clinic of Robert Hozman — Skokie, Illinois
- Klein And Associates M D P A — Hagerstown, Maryland
- DM Clinical Research 1 — Brookline, Massachusetts
- St Paul Rheumatology PA — Eagan, Minnesota
- Albuquerque Rehabilitation and Rheumatology — Albuquerque, New Mexico
- Joint and Muscle Research Institute — Charlotte, North Carolina
- Rheumatology Associates of Oklahoma — Oklahoma City, Oklahoma
- Altoona Center For Clinical Research — Duncansville, Pennsylvania
- Clinical Research Philadelphia — Philadelphia, Pennsylvania
- UT Southwestern — Dallas, Texas
- Arthritis and Rheumatology Research Institute — Frisco, Texas
- Naiara Alvarez MD Integrative Rheumatology of South TX — Harlingen, Texas
- AARA Clinical Research Lone Star Arthritis and Rheumatology — Irving, Texas
- DM Clinical Research — Tomball, Texas
- Velocity Clinical Research — Waco, Texas
- Seattle Rheumatology — Seattle, Washington
- Center of Rheumatic Diseases — Glendale, Wisconsin
📞 Contact the Study Coordinator
Phone: (844) 434-4210
Email: Participate-In-This-Study1@its.jnj.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Arthritis, Psoriatic
- A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice — Buenos Aires,
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug — Avondale, Arizona
- A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis — Jonesboro, Arkansas
- A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Avondale, Arizona
- A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Birmingham, Alabama
Explore by condition: All Arthritis, Psoriatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.